Orgenesis Inc. Files 8-K Report

Ticker: ORGS · Form: 8-K · Filed: Apr 22, 2025 · CIK: 1460602

Orgenesis INC. 8-K Filing Summary
FieldDetail
CompanyOrgenesis INC. (ORGS)
Form Type8-K
Filed DateApr 22, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-k, disclosure

TL;DR

Orgenesis filed an 8-K on 4/22/25 for 'Other Events' - details pending.

AI Summary

On April 22, 2025, Orgenesis Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. Specific details regarding the nature of these events, including any financial implications or new developments, are not elaborated upon in the provided text.

Why It Matters

This filing signals a material event has occurred for Orgenesis Inc., requiring public disclosure. Investors should look for further details to understand the impact on the company's operations or financial standing.

Risk Assessment

Risk Level: medium — The filing is an 8-K for 'Other Events' without immediate specific details, creating uncertainty for investors.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by Orgenesis Inc. in this 8-K filing?

The provided text of the 8-K filing does not specify the nature of the 'Other Events'.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on April 22, 2025.

What is the principal executive office address for Orgenesis Inc.?

The principal executive office address for Orgenesis Inc. is 20271 Goldenrod Lane, Germantown, MD 20876.

In which U.S. state is Orgenesis Inc. incorporated?

Orgenesis Inc. is incorporated in Nevada.

What is the Commission File Number for Orgenesis Inc.?

The Commission File Number for Orgenesis Inc. is 001-38416.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding Orgenesis Inc. (ORGS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing